Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit.

Ferrè C, de Guzmao BM, Morgades M, Lacoma A, Marcos P, Jiménez-Lorenzo MJ, Xicoy B, Misis M, Prat C, Bordejé ML, Domínguez J, Feliu E, Ribera JM.

Leuk Lymphoma. 2012 Oct;53(10):1966-70. doi: 10.3109/10428194.2012.543715.

PMID:
22938139
2.

Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus.

Bédos JP, Dumoulin JL, Gachot B, Veber B, Wolff M, Régnier B, Chevret S.

Crit Care Med. 1999 Jun;27(6):1109-15.

PMID:
10397214
3.

Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barré syndrome.

Schleicher GK, Black A, Mochan A, Richards GA.

Crit Care Med. 2003 Jun;31(6):1848-50.

PMID:
12794429
4.

Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.

Ferrà C, Marcos P, Misis M, Morgades M, Bordejé ML, Oriol A, Lloveras N, Sancho JM, Xicoy B, Batlle M, Klamburg J, Feliu E, Ribera JM.

Int J Hematol. 2007 Apr;85(3):195-202.

PMID:
17483054
5.

Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit.

Staudinger T, Stoiser B, Müllner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M.

Crit Care Med. 2000 May;28(5):1322-8.

PMID:
10834673
6.

Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.

Adlakha A, Pavlou M, Walker DA, Copas AJ, Dufty N, Batson S, Edwards SG, Singer M, Miller RF.

Int J STD AIDS. 2011 Sep;22(9):498-504. doi: 10.1258/ijsa.2011.010496.

PMID:
21890545
7.
8.

Long-term survival after intensive care unit admission with sepsis.

Sasse KC, Nauenberg E, Long A, Anton B, Tucker HJ, Hu TW.

Crit Care Med. 1995 Jun;23(6):1040-7.

PMID:
7774214
9.

The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country.

Zar HJ, Apolles P, Argent A, Klein M, Burgess J, Hanslo D, Bateman ED, Hussey G.

Pediatr Crit Care Med. 2001 Apr;2(2):108-112.

PMID:
12797868
10.

Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication.

Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA.

Crit Care Med. 2003 Jan;31(1):104-12.

PMID:
12545002
11.

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

Oriol A, Ribera JM, Bergua J, Giménez Mesa E, Grande C, Esteve J, Brunet S, Moreno MJ, Escoda L, Hernandez-Rivas JM, Hoelzer D.

Cancer. 2008 Jul 1;113(1):117-25. doi: 10.1002/cncr.23522.

12.
13.

Predictors of short and long-term outcome in patients with hematological disorders admitted to the intensive care unit for a life-threatening complication.

Cherif H, Martling CR, Hansen J, Kalin M, Björkholm M.

Support Care Cancer. 2007 Dec;15(12):1393-8. Epub 2007 May 22.

PMID:
17516092
14.

Human immunodeficiency virus infection and hospital mortality in acute lung injury patients.

Mendez-Tellez PA, Damluji A, Ammerman D, Colantuoni E, Fan E, Sevransky JE, Shanholtz C, Gallant JE, Pronovost PJ, Needham DM.

Crit Care Med. 2010 Jul;38(7):1530-5. doi: 10.1097/CCM.0b013e3181e2a44b.

PMID:
20453644
15.

ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey.

Gill JK, Greene L, Miller R, Pozniak A, Cartledge J, Fisher M, Nelson MR, Soni N.

Anaesthesia. 1999 Aug;54(8):727-32.

16.

[Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].

Lin Y, Zhu X, Liu F, Zhao YY, Du J, Yao GQ, Li WX, Jia XJ.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Aug;23(8):449-53. Chinese.

17.

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.

Wang ES, Straus DJ, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, Goy A, Hedrick E, Zelenetz AD, Noy A.

Cancer. 2003 Sep 15;98(6):1196-205.

18.

Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.

Monnet X, Vidal-Petiot E, Osman D, Hamzaoui O, Durrbach A, Goujard C, Miceli C, Bourée P, Richard C.

Crit Care. 2008;12(1):R28. doi: 10.1186/cc6806. Epub 2008 Jan 25. Erratum in: Crit Care. 2009;13(2)407.

19.

Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.

Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B.

AIDS. 2004 Jul 2;18(10):1429-33.

PMID:
15199319
20.

Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit.

van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI.

Eur J Clin Microbiol Infect Dis. 2011 Sep;30(9):1085-93. doi: 10.1007/s10096-011-1196-z. Epub 2011 Feb 18.

PMID:
21331480

Supplemental Content

Support Center